These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 11866276

  • 1. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K.
    Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
    [Abstract] [Full Text] [Related]

  • 2. Changes in pulmonary function in patients with ulcerative colitis.
    Mohamed-Hussein AA, Mohamed NA, Ibrahim ME.
    Respir Med; 2007 May; 101(5):977-82. PubMed ID: 17049827
    [Abstract] [Full Text] [Related]

  • 3. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV.
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [Abstract] [Full Text] [Related]

  • 4. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD, Bid HK, Ghoshal UC.
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [Abstract] [Full Text] [Related]

  • 5. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 6. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H.
    Nutrition; 2008 May; 24(7-8):694-702. PubMed ID: 18499398
    [Abstract] [Full Text] [Related]

  • 7. Low prevalence of pulmonary involvement in children with inflammatory bowel disease.
    Peradzyńska J, Krenke K, Lange J, Banaszkiewicz A, Łazowska-Przeorek I, Radzikowski A, Kulus M.
    Respir Med; 2012 Jul; 106(7):1048-54. PubMed ID: 22516040
    [Abstract] [Full Text] [Related]

  • 8. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibromyalgia in inflammatory bowel disease.
    Buskila D, Odes LR, Neumann L, Odes HS.
    J Rheumatol; 1999 May; 26(5):1167-71. PubMed ID: 10332985
    [Abstract] [Full Text] [Related]

  • 14. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
    Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES.
    Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L, Vavrecka A, Prikazska M, Drugda B, Hronec J, Senkova A, Drugdova M, Oltman M, Novotna T, Brezina M, Kratky A, Kristufek P.
    Hepatogastroenterology; 1999 Feb; 46(27):1714-9. PubMed ID: 10430329
    [Abstract] [Full Text] [Related]

  • 16. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E, Herzig KH, Szaflarska-Popawska A, Kiehne K, Socha P, Woś H, Kamińska B, Błaszczyński M, Cichy W, Bała G, Brodzicki J, Grzybowska-Chlebowczyk U, Walkowiak J.
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [Abstract] [Full Text] [Related]

  • 17. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A, Gasiorowska A, Małecka-Panas E.
    Pol Merkur Lekarski; 2004 Oct; 17 Suppl 1():22-6. PubMed ID: 15603341
    [Abstract] [Full Text] [Related]

  • 18. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F, López Vivancos J, Malagela JR.
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [Abstract] [Full Text] [Related]

  • 19. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkühn T, Parhofer KG, Göke B, Broedl UC.
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [Abstract] [Full Text] [Related]

  • 20. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I.
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.